Afraid of the wall of death? Considerations on monoclonal antibody characteristics that trigger aggregation during

Natalie Deiringer1, Wolfgang Friess1

  • 1Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Ludwig-Maximilians-Universität München, Munich, Germany.

Related Concept Videos